Free Trial
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel
NYSE:QGEN

Qiagen Q3 2026 Earnings Date & Estimates

Qiagen logo
$44.54 -0.25 (-0.56%)
Closing price 10/8/2026 03:59 PM Eastern
Extended Trading
$44.78 +0.24 (+0.55%)
As of 07:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Qiagen is expected to report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. The conference call is scheduled for November 4, 2026 at 9:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
9:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Qiagen in Q3 2026

Qiagen is expected to post earnings of $0.62 per share on revenue of $535.62 million. In the same quarter a year earlier Qiagen reported $0.64 per share on revenue of $532.58 million. Qiagen last reported on August 5, 2026, posting $0.62 per share and beating the $0.60 consensus estimate. Qiagen has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.62
Expected Revenue
$535.62 million
Prior-Year EPS
$0.64
Prior-Year Revenue
$532.58 million
Expected EPS Growth
-3.4%
Expected Revenue Growth
+0.6%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.62 (Beat by +$0.02)
Last Quarter Revenue
$535.04 million
EPS Beat Rate
6 of last 8 quarters

Prepare for the Q3 2026 Call

Qiagen Q3 2026 Earnings FAQ

Qiagen (NYSE:QGEN) is estimated to report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Qiagen's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 9:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Qiagen to post earnings of $0.62 per share for Q3 2026.

The consensus revenue estimate for Qiagen is $535.62 million for Q3 2026.

Qiagen Earnings Headlines

QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery
October 6 at 4:05 PM  |  businesswire.comhttps://www.businesswire.com/news/home/20261006274304/en/qiagen-expands-ai-powered-bioinformatics-for-research-and-drug-discovery/
Qiagen gains on report talks with strategic buyer have advanced
October 2, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4649918-qiagen-gains-on-report-talks-with-strategic-buyer-have-advanced
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
October 9 at 1:00 AM  |  InvestorPlace (Ad)
OmniAb (NASDAQ:OABI) versus Qiagen (NYSE:QGEN) Head-To-Head Survey
October 1, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31073489
Qiagen (QGEN), What Is Behind The Fresh Attention Now?
September 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/qiagen-qgen-behind-fresh-attention-031132397.html
What Qiagen (QGEN)'s Expanded Sepsis Testing Portfolio Means For Shareholders
September 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/qiagen-qgen-expanded-sepsis-testing-020901288.html
See More Qiagen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Qiagen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Qiagen and other key companies, straight to your email.

About Qiagen

Qiagen (NYSE:QGEN) (NYSE:QGEN) is a global provider of sample technologies, molecular testing solutions and bioinformatics products. The company develops tools that help researchers and healthcare professionals isolate, analyze and interpret biological materials, including DNA, RNA and proteins.

Its portfolio includes laboratory kits and instruments for sample preparation, polymerase chain reaction (PCR), next-generation sequencing, genotyping and molecular diagnostics. QIAGEN also provides digital and bioinformatics solutions used to manage and analyze biological data. Its products support applications in academic and pharmaceutical research, biotechnology, forensic testing, veterinary medicine and clinical healthcare.

QIAGEN was founded in 1984 and has expanded from a supplier of molecular biology research tools into a global life sciences and diagnostics company. Headquartered in Venlo, the Netherlands, it serves customers through operations and distribution networks across North America, Europe, Asia and other international markets. The company is led by Chief Executive Officer Thierry Bernard.

View Qiagen Profile
Earnings Tools